In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest on: Genome editing
Waubonsie students experiment with DNA with bioethics in mind
on April 20, 2018 at 3:35 pm
(Suzanne Baker / Naperville Sun) Editing DNA may be par for the course in Chris Schramm ... Valley High Schol senior Connor Born adds agents that will help edit the genome of a bacteria during one of teacher Chris Schramm's genetics classes Wednesday ... […]
This Gene-Editing Breakthrough Could Provide Hyper-Specific Cancer Diagnoses
on April 19, 2018 at 2:25 pm
The ability to edit outside of the cell, researchers said, could also reveal more about the mystery of how CRISPR actually works to modify the genome. Recently, working with different enzymes has led to breakthroughs including editing the epigenome instead ... […]
Don't Overregulate CRISPR Genome Editing
on April 19, 2018 at 2:23 pm
It looks like the current wave of new genetic engineering techniques will largely escape the bans, moratoria, and overregulation that greeted the first wave in the 1970s. More than 40 years ago, the announcement that researchers were able to splice ... […]
Genome editing identifies neural circuit behind leptin’s anti-obesity and anti-diabetes effects
on April 19, 2018 at 12:55 am
Revealing surprising answers to a long-standing enigma about the brain target of the anti-obesity hormone leptin, neuroscientists at Tufts University School of Medicine have used CRISPR genome editing to identify a neural circuit in the hypothalamus as the ... […]
Leptin's neural circuit identified—Genome-editing study reveals how hormone helps prevent both obesity and diabetes
on April 18, 2018 at 10:01 am
An infrared thermal image of two mouse littermates following CRISPR-mediated genome editing of leptin signaling reveals surprises. Leptin, a fat hormone identified over 20 years ago, acts in the brain to maintain body weight and blood glucose balance ... […]
Europe Genome Editing Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply and Forecast To 2021
on April 16, 2018 at 7:43 am
Browse market data tables and in-depth TOC of the Europe Genome Editing Market to 2021 @ https://www.marketdataforecast.com/market-reports/europe-genome-editing-market-2790/ Genome Editing uses a special type of enzyme called an engineered nuclease which ... […]
Breakthrough CRISPR Gene Editing Trial Set to Begin This Year
on April 16, 2018 at 3:08 am
Helen O’Neill, a geneticist from University College London (UCL), told the Telegraph: “Certainly, 2018 promises to be the big year for clinical trials using CRISPR based genome editing. Results presented by [CRISPR Therapeutics] at a haematology ... […]
Genome Engineering Market to Surpass US$ 8,512.5 Mn Threshold by 2025
on April 13, 2018 at 11:29 am
For instance, in 2017, Synthego Corporation—a U.S.-based company of genome engineering solutions—launched its CRISPRevolution Gene Knockout Kit (GKO), with the first guaranteed CRISPR gene editing solution. The new Synthego's kits rapidly modifies ... […]
CRISPR Has Made Its Way Into Popular Culture. How Accurate Is The Portrayal Of The Gene-Editing Technique?
on April 12, 2018 at 5:57 am
But it’s not every day we get to cover Dwayne “The Rock” Johnson. The Rock and the genome-editing technology meet in a new movie, “Rampage,” coming out Friday. Through a freak accident, a gorilla, a wolf, and a crocodile ingest some CRISPR complexes. […]
Gene editing regulations threaten sustainability of global food animal supply
on April 9, 2018 at 9:02 am
Led by Editor-in-Chief Rodolphe Barrangou, PhD, North Carolina State University, the Journal covers CRISPR biology, technology and genome editing, and commentary and debate of key policy, regulatory, and ethical issues affecting the field. For complete ... […]
via Google News and Bing News